Cargando…

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome

Detalles Bibliográficos
Autores principales:	Charra, B, Hachimi, A, Benslama, A, Motaouakkil, S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083994/ http://dx.doi.org/10.1186/cc7272

Ejemplares similares

Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome
por: Charra, Boubaker, et al.
Publicado: (2014)

Precocious tracheotomy versus prolonged intubation in a medical ICU
por: Charra, B, et al.
Publicado: (2008)

Rifampicin and colistin association in the treatment of severe multiresistant Acinetobacter baumannii infections
por: Charra, B, et al.
Publicado: (2008)

Scoring systems (APACHE II and Simplified Acute Physiology Score II) for predicting outcome in status asthmaticus
por: Hachimi, A, et al.
Publicado: (2009)

Contribution of noninvasive ventilation in the precocious extubation in the medical ICU
por: Charra, B, et al.
Publicado: (2009)

Immunological manifestations in paraphenylenediamine poisoning
por: Charra, B, et al.
Publicado: (2008)

Colistin monotherapy versus therapy combination
por: Charra, B, et al.
Publicado: (2010)

Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011)

Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study
por: El-Bayoumi, Mohammed A, et al.
Publicado: (2011)

Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis
por: Zaki, Hany A., et al.
Publicado: (2023)

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
por: Verboon, Christine, et al.
Publicado: (2021)

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome
por: Fokkink, Willem Jan R., et al.
Publicado: (2022)

Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
por: Garcia, Jao Jarro, et al.
Publicado: (2021)

Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome
por: Jain, Rajendra Singh, et al.
Publicado: (2014)

Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome
por: Mori, Izumi, et al.
Publicado: (2008)

Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
por: Madaan, Priyanka, et al.
Publicado: (2019)

Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barré syndrome
por: Incecik, Faruk, et al.
Publicado: (2011)

Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
por: Rajabally, Yusuf A.
Publicado: (2022)

Intravenous Immunoglobulin may Reverse Multisystem Inflammation in COVID-19 Pneumonitis and Guillain–Barré Syndrome
por: Chakraborty, Nilanchal, et al.
Publicado: (2020)

Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome()
por: Gupta, Subhadeep, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment with prognosis for the first six months of Guillain–Barré Syndrome in Somalia: Case series
por: Sidow, Nor Osman, et al.
Publicado: (2022)

A Rare case of Guillain-Barré syndrome in pregnancy treated with plasma exchange
por: Vasudev, Rahul, et al.
Publicado: (2014)

Successful Plasma Exchange in a Pregnant Patient with Guillain-Barré Syndrome and Thyrotoxicosis
por: Toydemir, Hülya E., et al.
Publicado: (2022)

Predisposing factors, neurological complications and sequels of guillain barre syndrome at discharge: experience in an ICU of a third level hospital
por: Portugal Rodríguez, E, et al.
Publicado: (2015)

Comparative study between intravenous immunoglobulins and standard treatment in septic patients
por: Hamed, G, et al.
Publicado: (2008)

Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin
por: Hou, Hui Qing, et al.
Publicado: (2014)

Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)

Use of intravenous immunoglobulin to treat sepsis in a general ICU
por: Drakeford, Y, et al.
Publicado: (2015)

New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases
por: Assini, Andrea, et al.
Publicado: (2020)

Treatment guidelines for Guillain–Barré Syndrome
por: Meena, A. K., et al.
Publicado: (2011)

Small volume plasma exchange for Guillain-Barré syndrome in resource poor settings: a safety and feasibility study
por: Islam, Md. Badrul, et al.
Publicado: (2017)

Usefulness of intravenous immunoglobulin administration to sepsis-induced coagulopathy in ICU patients
por: Matsumoto, N, et al.
Publicado: (2014)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
por: Baskin, E, et al.
Publicado: (2008)

Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns
por: Khanes, G, et al.
Publicado: (2012)

Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service
por: Saladi, SM, et al.
Publicado: (2008)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Therapeutic plasma exchange in pediatric patients of Guillain–Barre syndrome: Experience from a Tertiary Care Centre
por: Gajjar, Maitrey, et al.
Publicado: (2016)

Correction to: New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases
por: Assini, Andrea, et al.
Publicado: (2020)

Disturbance of Plasma Lipid Metabolic Profile in Guillain-Barre Syndrome
por: Tang, Hsiang-Yu, et al.
Publicado: (2017)

COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database
por: Keh, Ryan Y S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qdthusktbeu2os8qr8sf8m9jn3